amlodipine besylate; olmesartan medoxomil
AMLODIPINE AND OLMESARTAN MEDOXOMIL (amlodipine besylate; olmesartan medoxomil) by Matrix Surgical USA is medoxomil. Approved for hypertension, alone, other antihypertensive agents and 2 more indications. First approved in 2017.
Drug data last refreshed 21h ago
medoxomil. Amlodipine and olmesartan medoxomil is a combination of two antihypertensive drugs: a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker), amlodipine besylate, and an angiotensin II receptor blocker, olmesartan medoxomil. The amlodipine component of…
Worked on AMLODIPINE AND OLMESARTAN MEDOXOMIL at Matrix Surgical USA? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients